Pylarify (piflufolastat f-18)
Ended Awarded
- Contract number
- 36C26126N0102
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $758,763
Award facts
- Contract value 100% obligated
- $758,762.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed-price delivery order awarded to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc., to provide PYLARIFY (piflufolastat F-18), a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect, localize, and image prostate cancer. The $758,762.94 contract, awarded on October 1, 2025, has an ultimate completion date of September 30, 2026.
The contract was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is funded by the Department of Veterans Affairs (VA). PYLARIFY is a critical radiopharmaceutical product that enables advanced medical imaging for federal healthcare providers, particularly in the areas of cancer detection and treatment. Lantheus Medical Imaging, the parent company of Progenics Pharmaceuticals, holds several significant federal contract Indefinite Delivery Vehicles (IDVs) with the VA and Defense Health Agency, which facilitate the efficient procurement of radiopharmaceuticals and other specialized medical imaging products by government healthcare facilities.
Quick answers
Who was awarded contract 36C26126N0102?
36C26126N0102 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on October 1, 2025.
How much is contract 36C26126N0102 worth?
The government has obligated $758,763 on 36C26126N0102.
Is contract 36C26126N0102 an order under another contract?
Yes. 36C26126N0102 is a delivery order under 36F79725D0093, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26126N0102 competed?
The extent of competition for 36C26126N0102 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award